中国大陆地区暗色丝孢霉病(1987~2017年)回顾性分析

中国真菌学杂志　 2018, Vol. 13 　Issue (5): 272-276.

中国大陆地区暗色丝孢霉病(1987~2017年)回顾性分析

贺赟^1,2,3, 郑海林^1,2, 李筱芳^1,2, 吕桂霞^1,2, 沈永年^1,2, 刘维达^1,2

1. 北京协和医学院中国医学科学院皮肤病研究所, 南京 210042;
2. 江苏省皮肤病与性病分子生物学重点实验室, 南京 210042;
3. 宜兴市皮肤病医院皮肤科, 宜兴 214200

收稿日期:2018-02-27 出版日期:2018-10-28 发布日期:2018-10-28
通讯作者: 李筱芳,E-mail:lxf3568@163.com;刘维达,E-mail:liumyco@hotmail.com E-mail:lxf3568@163.com;liumyco@hotmail.com
作者简介:贺赟,女(汉族),硕士,住院医师.E-mail:19mxbj@163.com

A retrospective analysis of phaeohyphomycosis in the Mainland of China (1987-2017)

HE Yun^1,2,3, ZHENG Hai-ling^1,2, LI Xiao-fang^1,2, LV Gui-xia^1,2, SHEN Yong-nian^1,2, LIU Wei-da^1,2

1. Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing 210042;
2. Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing 210042;
3. Skin disease prevention and treatment institute of Yixing, Yixing 214200

Received:2018-02-27 Online:2018-10-28 Published:2018-10-28

摘要/Abstract

摘要：

目的了解中国大陆地区近30年暗色丝孢霉病的流行病学和诊治状况。方法通过CNKI、万方、维普、Embase和Pubmed检索1987~2017年中国大陆地区暗色丝孢霉病相关文献，进行数据分析和总结。结果共纳入文献106篇，共计有115例患者。感染类型以皮肤及皮下组织型为主，继发于皮肤屏障被破坏、特发性免疫功能异常最多。诊断主要依据真菌镜检、组织病理、真菌培养和分子鉴定。治疗以系统抗真菌药物为主，伊曲康唑为首选用药。107例患者中因该病死亡10例，占9.35%；其中以中枢神经系统型死亡率最高，达75%。结论中国大陆地区暗色丝孢霉病感染数有明显上升趋势。临床医生应提高该病各型临床及病原诊断水平，并积极开展分子鉴定和体外药物敏感性试验，为临床治疗提供更为有效的依据。

关键词: 暗色丝孢霉病, 诊断, 治疗

Abstract:

Objective To understand the epidemiology and treatment of phaeohyphomycosis in the mainland of China over 30 years. Methods Literature on phaeohyphomycosis of the Chinese mainland from 1987 to 2017 were collected by CNKI, WanFang, WeiPu, Embase and Pubmed and statistically analyzed. Results A total of 116 cases and 115 patients were included in the review. The type of phaeohyphomycosis is dominated by the infection of skin and subcutaneous tissue. The disease was mainly induced by the damage of the skin barrier and abnormal immune function. The diagnosis was mainly based on fungal microscopy, histopathology, fungal culture and molecular identification. The treatment was mainly based on systematic antifungal treatment. Itraconazole was the most commonly used drug. Ten patients were dead in 107 patients with prognostic information, accounted for 9.35% (10/107); Mortality of the central nervous system infection was highest, 75% (6/8) of the known prognostic population. Conclusion The number of cases of phaeohyphomycosis in the mainland of China has increased significantly in recent years. All health workers should raise the awareness of the disease, making early diagnosis and timely treatment, carrying out the molecular identificationin and in vitro drug sensitivity test at the same time, so as to provide more effective information for clinical treatment.

Key words: phaeohyphomycosis, diagnosis, treatment

中图分类号:

贺赟, 郑海林, 李筱芳, 吕桂霞, 沈永年, 刘维达. 中国大陆地区暗色丝孢霉病(1987~2017年)回顾性分析[J]. 中国真菌学杂志, 2018, 13(5): 272-276.

HE Yun, ZHENG Hai-ling, LI Xiao-fang, LV Gui-xia, SHEN Yong-nian, LIU Wei-da. A retrospective analysis of phaeohyphomycosis in the Mainland of China (1987-2017)[J]. Chinese Journal of Mycology, 2018, 13(5): 272-276.

参考文献

[1] Mahmoud A, John R. Antifungal Therapy[M]. 1rd ed. New York:Informa Healthcare. 2009:343-350.
[2] Ge YP, Lv GX, Shen YN, et al. First report of subcutaneous phaeohyphomycosis caused by Ochroconis tshawytschae in an immunocompetent patient[J]. Med Myco, 2012, 50(6):637-640.
[3] Li DM, Li RY, Hoog GS, et al. Exophiala asiatica, a new species from a fatal case in China[J]. Med Myco, 2009, 47(1):101-109.
[4] 何俊伟. 中枢神经系统暗色丝孢霉病1例报告并文献复习[D]. 福建医科大学, 2012.
[5] 张瑞珺, 王晓雯, 万喆,等. 播散性暗色丝孢霉病患者CARD9突变及相关免疫学研究[J]. 微生物与感染, 2017, 12(1):14-23.
[6] Yan XX, Yu CP, Fu XA, et al. CARD9 mutation linked to Corynespora cassiicola infection in a Chinese patient[J]. BrJDermato, 2015, 174(1):176.
[7] 戴文丽, 任忠芬, 万俊增, 等. 我国首例由棘状外瓶霉所致系统性暗色丝孢霉病报告[J]. 中华皮肤科杂志, 1987, 20(1):13.
[8] Isaisa R, García C, Isa M, et al. Subcutaneous phaeohyphomycosis (mycotic cyst).[J]. Clin Dermatol, 2012, 30(4):425-431.
[9] Revankar SG, Sutton DA. Melanized Fungi in Human Disease[J]. Clin Microbiol Rev, 2010, 23(4):884-928.
[10] Liu M, Xin X, Li J, et al. The first case of endophthalmitis due to Rhinocladiella basitona in an immunocompetent patient[J]. Diagn Microbiol Infect Dis, 2015, 83(1):49-52.
[11] Rampini SK, Zbinden A, Speck RF, et al. Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients[J]. BMCMicrobiol, 2016, 16(1):1-8.
[12] 胡冰, 李绍英, 胡惠丽, 等. 皮炎外瓶霉所致中枢神经系统感染一例并文献复习[J]. 中华儿科杂志, 2014, 52(8):620.
[13] Chakrabarti A, Kaur H, Rudramurthy SM, et al. Braina bscess due to Cladophialophora bantiana:a review of 124 cases[J]. Med Mycol, 2015, 54(2):193-195.
[14] Deng S, Pan W, Liao W, et al. Combination of amphotericin B and flucytosine against neurotropic species of melanized fungi causing primary cerebral phaeohyphomycosis.[J]. Antimicrob Agents Chemother, 2016, 60(4):2346-2351.
[15] Chowdhary A, Meis JF, Guarro J, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis:diseases caused by black fungi[J]. Clin Microbiol Infect, 2014, 20(Suppl3):47-75.